Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.

NCT Number	NCT07248371
Lead Sponsor	Chang Gung Memorial Hospital
Conditions	Metabolic Syndrome (MetS), Obesity & Overweight, Cardiovascular Diseases (CVD), Chronic Kidney Disease, Nonalcoholic Fatty Liver Disease, Healthy
Enrollment	6,266 participants
Start Date	2025-06-09
Primary Completion	2028-09-30 (estimated)
Study Completion	2035-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-11-25